Recombinant Human ATP-sensitive inward rectifier potassium channel 15 (KCNJ15)

Shipped with Ice Packs
In Stock

Description

Functional Roles in Physiology and Disease

KCNJ15 regulates potassium flux across cell membranes, impacting diverse biological processes:

Metabolic Regulation

  • Insulin secretion:

    • Inhibits glucose-stimulated insulin release in pancreatic β-cells .

    • Knockdown increases insulin secretion in diabetic mice (P = 0.0014) .

  • Gastric acid secretion: Mediates apical K⁺ supply for H⁺/K⁺-ATPase activity in parietal cells .

Immune Response

  • Tuberculosis defense: Upregulates intracellular K⁺, triggering apoptosis in infected macrophages to limit bacterial replication .

Cancer Pathogenesis

  • Tumor suppression:

    • Low expression correlates with poor prognosis in renal cell carcinoma (P = 0.0105) .

    • Overexpression in breast cancer cells reduces drug resistance and metastasis .

Neurological Function

  • Epilepsy: Modulates neuronal excitability; genetic variants linked to seizure disorders .

Table 2: Experimental Insights from KCNJ15 Studies

Study FocusKey FindingsSource
DiabetesSilencing KCNJ15 in β-cells enhances insulin secretion by 40% .
Cancer TherapyKCNJ15 overexpression reduces TNBC tumor growth by 60% in mice .
Infectious DiseaseKCNJ15 activation increases TB-infected cell apoptosis by 2.5-fold .
Cell MigrationKCNJ15 knockdown abolishes galvanotaxis (directed cell migration) .

Therapeutic and Research Applications

  • Drug development: Target for insulin sensitizers (diabetes) , chemosensitizers (cancer) , and host-directed therapies (infections) .

  • Diagnostic biomarker: Elevated KCNJ15 mRNA in type 2 diabetic islets ; low expression predicts aggressive renal cancer .

  • Tool for electrophysiology: Used to study potassium channel dynamics in heterologous systems (e.g., Xenopus oocytes) .

Challenges and Future Directions

  • Structural complexity: Lack of high-resolution 3D structures hinders drug design .

  • Species variability: Functional differences between human and rodent isoforms require validation .

  • Clinical translation: Most studies are preclinical; human trials are needed to assess therapeutic potential .

Product Specs

Form
Lyophilized powder
Note: We will prioritize shipping the format currently in stock. If you have specific format requirements, please indicate them during order placement.
Lead Time
Delivery times vary depending on the purchasing method and location. Please consult your local distributor for precise delivery estimates.
Note: All proteins are shipped with standard blue ice packs. Dry ice shipping requires advance notice and incurs additional charges.
Notes
Avoid repeated freeze-thaw cycles. Store working aliquots at 4°C for up to one week.
Reconstitution
Centrifuge the vial briefly before opening to collect the contents. Reconstitute the protein in sterile, deionized water to a concentration of 0.1-1.0 mg/mL. We recommend adding 5-50% glycerol (final concentration) and aliquoting for long-term storage at -20°C/-80°C. Our standard glycerol concentration is 50%, provided as a reference for customers.
Shelf Life
Shelf life depends on storage conditions, buffer composition, temperature, and protein stability. Generally, liquid formulations have a 6-month shelf life at -20°C/-80°C, while lyophilized forms have a 12-month shelf life at -20°C/-80°C.
Storage Condition
Upon receipt, store at -20°C/-80°C. Aliquoting is essential for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
Tag type is determined during the manufacturing process.
The specific tag type will be determined during production. If you require a particular tag, please specify this at the time of ordering, and we will prioritize its development.
Synonyms
KCNJ15; KCNJ14; ATP-sensitive inward rectifier potassium channel 15; Inward rectifier K(+ channel Kir1.3; Inward rectifier K(+ channel Kir4.2; Potassium channel, inwardly rectifying subfamily J member 15
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-375
Protein Length
full length protein
Species
Homo sapiens (Human)
Target Names
KCNJ15
Target Protein Sequence
MDAIHIGMSSTPLVKHTAGAGLKANRPRVMSKSGHSNVRIDKVDGIYLLYLQDLWTTVID MKWRYKLTLFAATFVMTWFLFGVIYYAIAFIHGDLEPGEPISNHTPCIMKVDSLTGAFLF SLESQTTIGYGVRSITEECPHAIFLLVAQLVITTLIEIFITGTFLAKIARPKKRAETIKF SHCAVITKQNGKLCLVIQVANMRKSLLIQCQLSGKLLQTHVTKEGERILLNQATVKFHVD SSSESPFLILPMTFYHVLDETSPLRDLTPQNLKEKEFELVVLLNATVESTSAVCQSRTSY IPEEIYWGFEFVPVVSLSKNGKYVADFSQFEQIRKSPDCTFYCADSEKQQLEEKYRQEDQ RERELRTLLLQQSNV
Uniprot No.

Target Background

Function

Inward rectifier potassium channels are characterized by their preferential inward potassium flux. Their voltage dependence is modulated by extracellular potassium concentration; increasing external potassium shifts the channel activation voltage to more positive potentials. Inward rectification is primarily attributed to internal magnesium block of outward current.

Gene References Into Functions

  1. KCNJ15 interacts with polyamines in weak electric field sensing. PMID: 26449415
  2. RNA-seq data reveals biallelic expression of KCNJ15 and 10 neighboring genes in at least one human tissue, suggesting KCNJ15 expression is independent of maternally inherited 5mCpG imprints at the WRB DMR in disomic or trisomic (Down syndrome) individuals. PMID: 27100087
  3. KCNJ15 plays a significant role in histamine-stimulated gastric acid secretion. PMID: 26108660
  4. A replication study in a larger Japanese population showed a significant association between rs3746876 within KCNJ15 and type 2 diabetes, though not fully replicating original findings. PMID: 23595124
  5. Kcnj15 downregulation increases insulin secretion in vitro and in vivo, potentially through a calcium-sensing receptor mechanism. PMID: 22566534
  6. KCNJ15 is identified as a susceptibility gene for type 2 diabetes among Asians. PMID: 20085713
  7. KCNJ15 contributes to the electrical integrity of bile-generating hepatocytes. PMID: 11804844
  8. The potential synergistic effects of KIR4.2 and KIR3.2 overexpression on Down's syndrome brain development are discussed. PMID: 15068243
  9. MUPP1 and Kir4.2 may form a protein complex in the nephron regulating potassium and other ion transport. PMID: 19420109
Database Links

HGNC: 6261

OMIM: 602106

KEGG: hsa:3772

STRING: 9606.ENSP00000331698

UniGene: Hs.411299

Protein Families
Inward rectifier-type potassium channel (TC 1.A.2.1) family, KCNJ15 subfamily
Subcellular Location
Membrane; Multi-pass membrane protein.

Q&A

What is KCNJ15 and what cellular functions does it mediate?

KCNJ15 (Potassium Inwardly Rectifying Channel Subfamily J Member 15) is a protein-coding gene that encodes the Kir4.2 protein, an integral membrane protein functioning as an inward-rectifier type potassium channel. This channel has a greater tendency to allow potassium to flow into a cell rather than out of it . KCNJ15 participates in a wide range of physiological responses and is present in most mammalian cells. The channel's voltage dependence is regulated by the concentration of extracellular potassium; as external potassium is raised, the voltage range of the channel opening shifts to more positive voltages. The inward rectification is mainly due to the blockage of outward current by internal magnesium .

What are the key structural and functional characteristics of the KCNJ15 channel?

KCNJ15/Kir4.2 belongs to the inward-rectifier potassium channel family (also known as 2-TM channels). Key functional characteristics include:

  • High open probability under normal conditions

  • Conductance of approximately 25 pS

  • pH sensitivity with a pKa of 7.1

  • Inhibition by intracellular acidification

  • Regulation by protein kinase C (PKC) activation (non-reversible)

  • Potential for heterodimerization with related channel Kir5.1, which alters functional properties

  • Contains important regulatory sites including a C-terminal tyrosine that affects trafficking to the membrane

Mutation of an extracellular lysine residue can result in a 6-fold increase in K+ current, while removal of the C-terminal tyrosine increases K+ current more than 10-fold, primarily through increased protein trafficking to the membrane rather than changes in single-channel conductance .

What are the recommended methods for studying KCNJ15 expression in different tissue samples?

For investigating KCNJ15 expression in various tissues, a multi-method approach is recommended:

  • Quantitative RT-PCR: For accurate measurement of KCNJ15 mRNA levels in different tissues. This technique was used in epilepsy studies to identify KCNJ15 downregulation (log2 Fold change = -1.0025) in epileptic temporal lobe tissue compared to controls .

  • Immunohistochemistry/Immunofluorescence: For protein-level detection and localization within tissues. This approach can verify co-localization with interacting proteins, as demonstrated in studies showing KCNJ15 interaction with the Calcium-sensing receptor in human kidney .

  • Western Blotting: For quantitative analysis of protein expression. This technique can be combined with specific treatments (e.g., CDK4/6 inhibitors) to assess changes in expression levels under different conditions .

  • Expression Quantitative Trait Loci (eQTL) Analysis: For evaluating how genetic variants affect gene expression. For example, the polymorphism rs2833098 has been associated with KCNJ15 expression levels in human temporal lobe brain tissue, with the AA genotype linked to downregulated expression compared to GG and GA genotypes .

What techniques can be used to assess KCNJ15 channel functionality in cellular models?

Several electrophysiological and molecular techniques can be employed to study KCNJ15 channel functionality:

  • Voltage Clamp Measurements: Particularly using Xenopus oocyte expression systems, this technique allows direct measurement of channel conductance, open probability, and response to various stimuli. Previous studies have used this approach to characterize Kir4.2's pH sensitivity and response to PKC activation .

  • Patch Clamp Recording: For single-channel analysis to determine conductance, open probability, and gating kinetics in native cells or heterologous expression systems.

  • Fluorescent Voltage/Ion Sensors: To visualize channel activity in real-time across cell populations.

  • Site-Directed Mutagenesis: To investigate the functional importance of specific amino acid residues, as demonstrated in studies showing increased K+ current following mutation of extracellular lysine or C-terminal tyrosine residues .

  • Heterologous Expression Systems: For studying channel properties in isolation or in combination with potential interacting proteins.

How is KCNJ15 implicated in epilepsy and what methodological approaches are used to study this association?

KCNJ15 has emerged as a candidate gene in epilepsy research, with several lines of evidence supporting its role:

  • Differential Expression Analysis: Studies have shown that KCNJ15 is significantly downregulated in epileptic temporal lobe brain tissue compared to controls (adjusted P = 0.0146, log2 Fold change = -1.0025) . The table below summarizes these findings:

Adjusted P valueP valuetBlog2FC
0.01469.00E-05-4.75011.5103-1.0025
  • eQTL Analysis: Genetic variants such as rs2833098 have been associated with KCNJ15 expression levels in human temporal lobe brain tissue, suggesting a genetic component to expression regulation in epilepsy-relevant brain regions .

  • Gene Co-expression Network Analysis: This approach has identified genes functionally associated with KCNJ15 in brain tissue, including A1CF, RABAC1, CYP2A6, SIGLEC6, and CRHR2, providing insights into potential regulatory networks .

  • Microglia Activation Studies: KCNJ15 is involved in microglial activation, and epilepsy has been linked to microglial activation through mechanisms including increased excitability and inflammation .

  • Animal Models: Researchers can use genetically modified animals with altered KCNJ15 expression to study epilepsy phenotypes and electrophysiological changes.

What role does KCNJ15 play in drug resistance mechanisms, and how can this be experimentally investigated?

KCNJ15 has been implicated in promoting drug resistance through specific molecular mechanisms:

  • Collagen Gel Droplet-Embedded Drug Sensitivity Test (CD-DST): This technique can be used to evaluate in vitro sensitivity of KCNJ15-positive and negative primary tumor cells to various drugs, such as CDK4/6 inhibitors .

  • Cell Separation Techniques: Tumor specimens can be processed to separate KCNJ15-positive and KCNJ15-negative cells using antibody-based approaches:

    • Incubation with KCNJ15 antibody

    • Secondary incubation with Anti-mouse IgG1-microbeads

    • Magnetic separation using columns and separators

  • Co-Immunoprecipitation (Co-IP) Assays: These assays have demonstrated interaction between KCNJ15 and V-ATPase components (ATP6V0A1 and ATP6V1B2), and have shown that KCNJ15 can negatively modulate V-ATPase activity . This interaction can be modulated by compounds such as concanamycin A (CMA) and bafilomycin (BAF), which weaken or block the binding of KCNJ15 to these V-ATPase subunits .

  • Computer Simulation Studies: Molecular modeling has identified specific interaction sites between compounds like CMA and both KCNJ15 and V-ATPase subunits, which may inhibit their interaction .

  • Animal Models: Xenograft models using KCNJ15-overexpressing cells (e.g., OE KCNJ15 MDA-MB-231 cells inoculated into BALB/c nude mice) can be used to study drug resistance mechanisms in vivo .

How does KCNJ15 contribute to electric field sensing (galvanotaxis/electrotaxis), and what experimental approaches can elucidate this mechanism?

KCNJ15/Kir4.2 has been identified as a key component in sensing weak electric fields during galvanotaxis, a process where electric fields guide cell migration. The experimental approaches to study this include:

  • RNAi Screening: Large-scale systematic screens targeting ion transporters have identified KCNJ15 as critical for galvanotaxis. Knockdown of KCNJ15 specifically abolishes galvanotaxis without affecting basal motility or directional migration in scratch assays .

  • Polyamine Manipulation Studies: These experiments reveal that:

    • Depletion of cytoplasmic polyamines (positively charged small molecules that regulate Kir4.2) completely inhibits galvanotaxis

    • Increasing intracellular polyamines enhances galvanotaxis in a Kir4.2-dependent manner

    • Expression of polyamine-binding defective mutants of KCNJ15 significantly decreases galvanotaxis

  • Phosphoinositide Localization Studies: Knockdown or inhibition of KCNJ15 prevents phosphatidylinositol 3,4,5-triphosphate (PIP3) from distributing to the leading edge of migrating cells .

  • Mutant Expression Studies: Expression of polyamine-binding defective mutants can help determine the specific domains involved in electric field sensing .

This research suggests a two-molecule sensing mechanism where KCNJ15/Kir4.2 couples with polyamines to sense weak electric fields, representing a novel paradigm for understanding cellular responses to physical stimuli .

What protein-protein interactions are critical for KCNJ15 function and how can they be methodologically investigated?

Several important protein-protein interactions influence KCNJ15 function and can be studied using various approaches:

  • Yeast Two-Hybrid Screening: This approach has identified interaction between KCNJ15 and the Calcium-sensing receptor in human kidney .

  • Co-Immunoprecipitation (Co-IP): This technique can verify interactions at the protein level, as demonstrated for:

    • KCNJ15 and Calcium-sensing receptor

    • KCNJ15 and V-ATPase subunits (ATP6V0A1 and ATP6V1B2)

    • KCNJ15 and Interleukin 16

  • Immunofluorescence Co-localization: This approach provides spatial information about protein interactions within cells .

  • Proximity Ligation Assays: For detecting protein interactions with high sensitivity in situ.

  • Functional Modification Studies: Using compounds like concanamycin A (CMA) and bafilomycin (BAF) to modulate protein interactions and assess functional outcomes .

  • Co-expression Studies: Investigating how co-expression with related channels (e.g., Kir5.1) affects function, potentially through heterodimerization .

  • Gene Co-expression Network Analysis: This computational approach has identified genes potentially functionally associated with KCNJ15, including A1CF, RABAC1, CYP2A6, SIGLEC6, and CRHR2 .

How might KCNJ15 contribute to microglial activation in neurological disorders, and what experimental models can address this question?

KCNJ15 has been linked to microglial activation, which plays a role in various neurological disorders including epilepsy and potentially Alzheimer's disease:

  • Primary Microglial Cultures: Can be used to study how KCNJ15 modulation affects microglial activation states, inflammatory cytokine production, and phagocytic activity.

  • Brain Slice Electrophysiology: To investigate how KCNJ15-mediated microglial activation influences neuronal excitability and network activity.

  • In Vivo Microglia Imaging: Using two-photon microscopy in animal models with altered KCNJ15 expression to visualize microglial dynamics in real-time.

  • Conditional Knockout Models: Cell-type specific deletion of KCNJ15 in microglia can help determine its direct role in microglial function.

  • Transcriptomic Analysis: Single-cell RNA sequencing of microglia from normal and pathological tissues can reveal how KCNJ15 expression correlates with microglial activation states.

The role of KCNJ15 in microglial activation may explain its association with epilepsy, as microglial activation can lead to increased neural excitability and inflammation . Furthermore, the positive association between KCNJ15 transcript levels and Alzheimer's disease suggests shared pathogenic mechanisms between these neurological conditions .

What are the implications of KCNJ15 polymorphisms for personalized medicine approaches, and how can these be studied?

Genetic variations in KCNJ15 have potential implications for personalized medicine, particularly in conditions like epilepsy and potentially drug resistance in cancer:

  • Genome-Wide Association Studies (GWAS): Can identify KCNJ15 polymorphisms associated with disease risk or treatment response.

  • Expression Quantitative Trait Loci (eQTL) Analysis: This approach has already identified that the rs2833098 polymorphism affects KCNJ15 expression in temporal lobe brain tissue, with the AA genotype associated with downregulated expression compared to GG and GA genotypes .

  • Functional Genomics: Using CRISPR-Cas9 to introduce specific polymorphisms and assess their impact on channel function and cellular phenotypes.

  • Patient-Derived Cell Models: Developing induced pluripotent stem cells (iPSCs) from patients with different KCNJ15 polymorphisms and differentiating them into relevant cell types for functional studies.

  • Pharmacogenomic Studies: Assessing how KCNJ15 variants affect response to various drugs, particularly anti-epileptic medications or cancer therapeutics.

  • Clinical Correlation Studies: Correlating KCNJ15 polymorphisms with clinical outcomes, treatment responses, and adverse effects in patient cohorts.

Understanding the functional consequences of KCNJ15 polymorphisms could lead to more personalized treatment approaches, particularly in epilepsy management where drug resistance remains a significant challenge. Additionally, given KCNJ15's role in drug resistance mechanisms, polymorphisms affecting its function might influence cancer treatment outcomes .

What expression systems are most effective for producing functional recombinant KCNJ15, and what purification strategies yield highest activity?

For successful production of functional recombinant KCNJ15, researchers should consider:

  • Expression Systems:

    • Mammalian Cell Systems: HEK293 or CHO cells often provide proper post-translational modifications and folding for membrane proteins

    • Xenopus Oocytes: Effective for functional studies though not for large-scale purification

    • Insect Cell Systems: Baculovirus-infected Sf9 or High Five cells can produce higher yields while maintaining proper folding

  • Purification Strategies:

    • Affinity Tags: Addition of His6, FLAG, or other affinity tags to facilitate purification

    • Detergent Solubilization: Critical for extracting membrane proteins; mild detergents like DDM, LMNG, or digitonin are preferred

    • Size Exclusion Chromatography: For final polishing and ensuring homogeneity of the purified protein

    • Lipid Reconstitution: Reconstitution into nanodiscs or liposomes to maintain native-like environment

  • Activity Assessment:

    • Electrophysiological Recordings: Patch-clamp or planar lipid bilayer recordings to confirm channel functionality

    • Fluorescence-Based Assays: Using potassium-sensitive fluorescent dyes to assess channel activity

    • Binding Assays: To confirm interaction with polyamines and other regulatory molecules

The choice of expression system should be guided by the specific experimental requirements, with mammalian systems generally preferred when post-translational modifications are critical for function, and bacterial systems avoided due to the complexity of properly folding this integral membrane protein.

What methodologies can be employed to study the structure-function relationships of recombinant KCNJ15?

Investigating structure-function relationships of KCNJ15 requires a combination of structural biology and functional approaches:

  • Cryo-Electron Microscopy (Cryo-EM): Enables visualization of membrane proteins in near-native states without crystallization, ideal for determining KCNJ15 structure in various conformational states.

  • Site-Directed Mutagenesis: Systematically modifying key residues to assess their contribution to:

    • Channel conductance

    • Polyamine binding (critical for galvanotaxis)

    • pH sensitivity (pKa = 7.1)

    • Protein-protein interactions (e.g., with V-ATPase subunits or Calcium-sensing receptor)

  • Molecular Dynamics Simulations: To model channel dynamics, ion permeation, and interaction with regulatory molecules or drugs.

  • Hydrogen-Deuterium Exchange Mass Spectrometry (HDX-MS): For studying protein dynamics and conformational changes under different conditions.

  • Voltage-Clamp Fluorometry: Combining electrophysiological recordings with fluorescence measurements to correlate structural changes with functional states.

  • Cross-linking Coupled with Mass Spectrometry: To identify interaction interfaces between KCNJ15 and its binding partners.

  • Computer Simulation: Modeling approaches have been used to identify specific interaction sites between compounds (like CMA) and both KCNJ15 and its interacting proteins .

These approaches can provide insights into how specific structural elements contribute to KCNJ15's unique functions, including its role in galvanotaxis, pH sensing, and interaction with regulatory proteins.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.